BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 122852)

  • 1. Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob/ob mice.
    Batchelor BR; Stern JS; Johnson PR; Mahler RJ
    Metabolism; 1975 Jan; 24(1):77-91. PubMed ID: 122852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
    Chen NG; Tassava TM; Romsos DR
    J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice.
    Cuendet GS; Loten EG; Jeanrenaud B; Renold AE
    J Clin Invest; 1976 Nov; 58(5):1078-88. PubMed ID: 993331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.
    Tassava TM; Okuda T; Romsos DR
    Am J Physiol; 1992 Mar; 262(3 Pt 1):E338-43. PubMed ID: 1550226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice.
    Okuda T; Romsos DR
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):801-5. PubMed ID: 7894518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity.
    Dubuc PU
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E550-5. PubMed ID: 1415535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin production by pancreatic islets of obese-hyperglycemic mice cultured for one week in different glucose concentrations.
    Andersson A; Asplund K; Larkins R
    Acta Physiol Scand; 1978 Dec; 104(4):377-85. PubMed ID: 364930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity.
    Mahler RJ
    Acta Diabetol Lat; 1981; 18(1):1-17. PubMed ID: 6452013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion and the morphological and metabolic characteristics of pancreatic islets of hyperthyroid ob/ob mice.
    Lenzen S; Klöppel G
    Endocrinology; 1978 Nov; 103(5):1546-55. PubMed ID: 371951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved glucose and lipid metabolism in genetically obese mice lacking aP2.
    Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS
    Endocrinology; 2000 Sep; 141(9):3388-96. PubMed ID: 10965911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects.
    Le Marchand Y; Loten EG; Assimacopoulos-Jeannet F; Forgue ME; Freychet P; Jeanrenaud B
    Diabetes; 1977 Jun; 26(6):582-90. PubMed ID: 140828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic beta-cells.
    Lundquist I; Alm P; Salehi A; Henningsson R; Grapengiesser E; Hellman B
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1055-63. PubMed ID: 14534076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of insulin secretory function in young obese hyperglycemic mice (Umeå ob/ob).
    Edvell A; Lindström P
    Metabolism; 1995 Jul; 44(7):906-13. PubMed ID: 7616850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.